Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenni L Loyall

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunological Investigations|April 18, 2020
Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory MicroenvironmentsGautam N Shenoy, Maulasri Bhatta, Jenni L Loyall, et al.
Clinical Immunology (Orlando, Fla.)|September 28, 2005
B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cellsQiang Lou, Thomas F Conway, Nejat K Egilmez, et al.
Clinical Immunology (Orlando, Fla.)|April 28, 2009
IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironmentsMichelle R Simpson-Abelson, Vivek S Purohit, Wing Man Pang, et al.
Clinical & Translational Immunology|February 8, 2021
Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platformGautam N Shenoy, Christopher J Greene, Maulasri Bhatta, et al.
Cancer Immunity|July 25, 2013
Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cellsMichelle R Simpson-Abelson, Jenni L Loyall, Heather K Lehman, et al.
Cancer Immunity|July 26, 2013
Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft modelSandra J Yokota, John G Facciponte, Raymond J Kelleher, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironmentsMaulasri Bhatta, Gautam N Shenoy, Jenni L Loyall, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunological Investigations|April 18, 2020
Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory MicroenvironmentsGautam N Shenoy, Maulasri Bhatta, Jenni L Loyall, et al.
Clinical Immunology (Orlando, Fla.)|September 28, 2005
B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cellsQiang Lou, Thomas F Conway, Nejat K Egilmez, et al.
Clinical Immunology (Orlando, Fla.)|April 28, 2009
IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironmentsMichelle R Simpson-Abelson, Vivek S Purohit, Wing Man Pang, et al.
Clinical & Translational Immunology|February 8, 2021
Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platformGautam N Shenoy, Christopher J Greene, Maulasri Bhatta, et al.
Cancer Immunity|July 25, 2013
Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cellsMichelle R Simpson-Abelson, Jenni L Loyall, Heather K Lehman, et al.
Cancer Immunity|July 26, 2013
Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft modelSandra J Yokota, John G Facciponte, Raymond J Kelleher, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironmentsMaulasri Bhatta, Gautam N Shenoy, Jenni L Loyall, et al.
Pageof 1